Anebulo Pharmaceuticals I... (ANEB)
NASDAQ: ANEB
· Real-Time Price · USD
2.44
-0.01 (-0.41%)
At close: Sep 25, 2025, 3:59 PM
2.44
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-0.41% (1D)
Bid | 2.4 |
Market Cap | 100.25M |
Revenue (ttm) | n/a |
Net Income (ttm) | -7.69M |
EPS (ttm) | -0.25 |
PE Ratio (ttm) | -9.76 |
Forward PE | -5.1 |
Analyst | Hold |
Dividends | n/a |
Ask | 2.53 |
Volume | 45,736 |
Avg. Volume (20D) | 433,226 |
Open | 2.41 |
Previous Close | 2.45 |
Day's Range | 2.39 - 2.49 |
52-Week Range | 0.80 - 3.42 |
Beta | -0.89 |
Ex-Dividend Date | n/a |
About ANEB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANEB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANEB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+17.91%
Anebulo Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
2 months ago
+81.97%
Anebulo Pharmaceuticals shares are trading higher after the company announced a reverse stock split with a ratio of at least 1-for-2500.

2 months ago · businesswire.com
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common StockAUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic ...